Funding for this research was provided by:
South African Medical Research Council (A0X331)
Novo Nordisk Fonden (NNF10CC1016517)
Received: 4 September 2020
Accepted: 29 October 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: Ethical approval for blood collection and analysis of the patients with COVID-19, T2DM and healthy individuals, was given by the Health Research Ethics Committee (HREC) of Stellenbosch University (reference number: 9521). This laboratory study was carried out in strict adherence to the International Declaration of Helsinki, South African Guidelines for Good Clinical Practice and the South African Medical Research Council (SAMRC), Ethical Guidelines for research. Consent was obtained from all participant. Patients or the public WERE NOT involved in the design, or conduct, or reporting, or dissemination plans of our research.
: All authors approved submission of the paper.
: The authors have no competing interests to declare.